Annika L. Kilian

Annika L. Kilian has extensive work experience in the field of bioinformatics and molecular pathogenesis. Annika L. is currently employed as a Senior Scientist Bioinformatics at Oncimmune since March 2022. Prior to this, Annika worked as a PhD Candidate at Universität Duisburg-Essen from January 2017 to February 2022, focusing on the molecular pathogenesis of classical Hodgkin lymphoma. Annika L. conducted CRISPR/Cas9-mediated gene knockout experiments and performed functional analysis of cell phenotypes using techniques such as FACS analysis, cell sorting, qPCR, and Western Blot. Before their PhD, Annika worked as a Wissenschaftlicher Mitarbeiter at Radboud University Medical Centre Nijmegen from October 2016 to January 2017 and as a Master Student from April 2016 to September 2016. Annika L. also gained internship experience at Henkel in early 2016 and at Forschungszentrum Jülich and Universitätsklinikum Bonn in 2015. Additionally, Annika worked as a Student Assistant and Bachelor Student at Universität Duisburg-Essen from September 2013 to August 2015.

Annika L. Kilian's education history begins in 2011 when they enrolled at the University of Duisburg-Essen for their bachelor's degree in Medizinische Biologie. Annika L. completed their bachelor's degree in 2014.

Following their bachelor's program, they pursued further education at the same university and obtained a master's degree in Medizinische Biologie between 2014 and 2016.

In 2017, Annika joined the BIOME Graduate School of Biomedical Science at the University of Duisburg-Essen. Annika L. engaged in the "Tumour and Signalling" Core program, which they completed in 2019.

Lastly, in 2019, Annika enrolled at the University of Düsseldorf to study Quantitative Biologie, though the information does not indicate the completion date or the degree obtained from this program.